Our doctors use this test on patients as young as six months to test for vision and optic nerve disorders. For example, glaucoma, MS and amblyopia. It can also be used to detect neuro-visual problems caused by traumatic brain injury or stroke. We are the only office in the Milwaukee metro area where this testing is currently available.
Visit our section on Diopsys for further information.
An evaluation of the retina is an important part of a comprehensive eye exam. In addition to a dilated exam, the Optomap® retinal exam allows doctors to take a state-of-the-art picture of each patient's retina (the back of the eye). This picture allows the doctor to evaluate the eye for ocular diseases, as well detect problems in the patient's overall health, such as hypertension or diabetes. These pictures are offered as an optional test at our New Berlin location.
OCT (Optical Coherence Tomography)
The OCT is a computerized scanning laser that takes a non-invasive picture of the layers of the retina. This device is often used to diagnose and monitor a variety of ocular diseases, such as glaucoma, macular degeneration, and diabetic retinopathy.
A visual field test is designed to map a person's peripheral vision. This computerized test consists of responding to a flash of light that is perceived at different points in the visual field. A visual field is commonly run on glaucoma patients, but can used to diagnose a variety of conditions.
Pachymetry measures the thickness of the cornea and is commonly done on glaucoma patients.
Gonioscopy allows the doctor to view the anatomy of the eye and its drainage system and is often done on glaucoma patients.
PHP (Preferential Hyperacuity Perimeter)
This test is conducted on patients with macular degeneration (AMD) and measures subtle variations in the central visual field. Often the PHP is repeated on a regular basis to monitor the progression of AMD.
QuantifEYE® MPOD (Macular Pigment Optical Density level)
This test is conducted as part of our comprehensive eye exam and measures the pigment level of the macula, the MPOD score. This measurement, along with other risk factors, helps the doctor determine if patients may be at risk for developing macular degeneration in the future. For patients who are at risk, the doctor may recommend a combination of vitamins to help reduce the risk for this disease.
LipiFlow® treats Dry Eye and Meibomian Gland Dysfunction (MGD). MGD affects 86% of all those with Dry Eye and it's treatable. While there are multiple choices available for treating MGD, LipiFlow® is the only FDA-cleared device for removing gland blockages and restoring gland function. Through advances in the application of Vectored Thermal Pulsation (VTP™) technology, the LipiFlow® treatment utilizes a patented algorithm of heat applied to the inner eyelids and massage to remove the obstructions in your meibomian glands. For more informaiton on LipiFlow® please ask us or visit lipiflow.com.